149 Results

People

  1. Chi
    Chi
  2. Barakat
    Barakat
  3. Spriggs
    Spriggs
  4. Abu-Rustum
    Abu-Rustum
  5. Aghajanian
    Aghajanian
  6. Sabbatini
    Sabbatini
  7. Sonoda
    Sonoda
  8. Iasonos
    Iasonos
  9. Hensley
    Hensley
  10. Levine
    Levine

Groups

  1. Gynecology Disease Management Team (75)
  2. Surgery (70)
  3. Department of Medicine (56)
  4. Solid Tumor Oncology Division (55)
  5. GDMT, Surgery (46)
  6. Gynecologic Medicine Service (44)
  7. GDMT, Medicine (42)
  8. Epidemiology and Biostatistics (23)
  9. Biostatistics Service (22)
  10. Survivorship Research (17)
  1. "ca 125 antigen"
Formats
  1. Journal Article (145)
  2. Conference Paper (2)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. Gynecology Disease Management Team (75)
  2. Surgery (70)
  3. Department of Medicine (56)
  4. Solid Tumor Oncology Division (55)
  5. GDMT, Surgery (46)
  6. Gynecologic Medicine Service (44)

More Groups

People
  1. Dennis Chi (31)
  2. Richard Barakat (24)
  3. David Spriggs (22)
  4. Paul Sabbatini (21)
  5. Nadeem Abu-Rustum (19)
  6. Carol Aghajanian (17)

More People

Years
  1. 2025 (3)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (2)
  5. 2021 (1)
  6. 2020 (4)

More Years

Publications
  1. Gynecologic Oncology (32)
  2. Journal of Clinical Oncology (13)
  3. International Journal of Gynecological Cancer (8)
  4. Cancer (6)
  5. Gynecologic Oncology Reports (5)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. Elsevier Inc. (41)
  2. American Society of Clinical Oncology (13)
  3. Lippincott Williams & Wilkins (13)
  4. Springer (8)
  5. Wiley Blackwell (8)
  6. American Association for Cancer Research (7)

More Publishers

Results (149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy
    Journal Article

    Boland, J. L.; Zhou, Q.; Iasonos, A. E.; O'Cearbhaill, R. E.; Konner, J.; Callahan, M.; Friedman, C.; Aghajanian, C.; Sabbatini, P.; Zamarin, D.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial
    Journal Article

    Koole, S.; Van Stein, R.; Sikorska, K.; Barton, D.; Perrin, L.; Brennan, D.; Zivanovic, O.; Mosgaard, B. J.; Fagotti, A.; Colombo, P. E.; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Galectins and ovarian cancer
    Review

    Shimada, C.; Xu, R.; Al-Alem, L.; Stasenko, M.; Spriggs, D. R.; Rueda, B. R.
    Cancers (2020)

    Fulltext@MSK | Save
  • Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma
    Journal Article

    Zhu, G.; Benayed, R.; Ho, C.; Mullaney, K.; Sukhadia, P.; Rios, K.; Berry, R.; Rubin, B. P.; Nafa, K.; Wang, L.; more...
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment
    Journal Article

    Aloisi, A.; Casanova, J. M.; Tseng, J. H.; Seader, K. A.; Nguyen, N. T.; Alektiar, K. M.; Makker, V.; Chiang, S.; Soslow, R. A.; Leitao, M. M. Jr; more...
    Gynecologic Oncology (2018)

    Fulltext@MSK | Save
  • Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Tew, W. P.; Sill, M. W.; Walker, J. L.; Secord, A. A.; Bonebrake, A. J.; Schilder, J. M.; Stuckey, A.; Rice, L.; Tewari, K. S.; Aghajanian, C. A.
    Gynecologic Oncology (2018)

    Fulltext@MSK | Save
  • Genomic analysis reveals distinct subtypes in two rare cases of primary ovarian lymphoma
    Journal Article

    Khattar, P.; Bedi, P.; Gonzalez, M.; Zhong, M.; Yin, C.; Huang, W.; Islam, H. K.; Fallon, J. T.
    Pathology Research and Practice (2018)

    Fulltext@MSK | Save
  • Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
    Journal Article

    Coleman, R. L.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A.; Scambia, G.; more...
    Lancet (2017)

    Fulltext@MSK | Save
  • Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
    Journal Article

    Balachandran, V. P.; Luksza, M.; Zhao, J. N.; Makarov, V.; Moral, J. A.; Remark, R.; Herbst, B.; Askan, G.; Bhanot, U.; Senbabaoglu, Y.; more...
    Nature (2017)

    Fulltext@MSK | Save
  • ACR Appropriateness Criteria® Ovarian Cancer Screening
    Journal Article

    Pandharipande, P. V.; Lowry, K. P.; Reinhold, C.; Atri, M.; Benson, C. B.; Bhosale, P. R.; Green, E. D.; Kang, S. K.; Lakhman, Y.; Maturen, K. E.; more...
    Journal of the American College of Radiology (2017)

    Fulltext@MSK | Save